美托洛尔、醋丁洛尔和普萘洛尔对人体抗脂解作用的比较。
Comparison of the antilipolytic effect of metoprolol, acebutolol, and propranolol in man.
作者信息
Newman R J
出版信息
Br Med J. 1977 Sep 3;2(6087):601-3. doi: 10.1136/bmj.2.6087.601.
Abstract
Metoprolol and acebutolol, two supposedly cardioselective beta-adrenoceptor antagonists, were tested in 11 healthy men against propranolol, a non-selective drug, for their effect on plasma free fatty acid concentrations before and after insulin. The fasting concentrations of free fatty acid were significantly reduced after acebutolol and propranolol, and their return to normal after insulin was delayed. Metoprolol had no significant effect on free fatty acid levels either before or after insulin. Although both selective and non-selective beta-blocking drugs should be expected to delay the return of free fatty acid values to normal after insulin, in contrast to propranolol and acebutolol, metoprolol had no such effect. This suggests that metoprolol may not be as effective as the other two drugs in controlling lipid metabolism during long-term treatment with beta-adrenoceptor antagonists.
摘要
美托洛尔和醋丁洛尔这两种被认为具有心脏选择性的β-肾上腺素能受体拮抗剂，在11名健康男性中与非选择性药物普萘洛尔进行了对比测试，观察它们对胰岛素前后血浆游离脂肪酸浓度的影响。醋丁洛尔和普萘洛尔使空腹游离脂肪酸浓度显著降低，且胰岛素作用后其恢复正常的时间延迟。美托洛尔对胰岛素前后的游离脂肪酸水平均无显著影响。尽管选择性和非选择性β受体阻滞剂都应会延迟胰岛素作用后游离脂肪酸值恢复正常的时间，但与普萘洛尔和醋丁洛尔不同，美托洛尔没有这种作用。这表明在长期使用β-肾上腺素能受体拮抗剂治疗期间，美托洛尔在控制脂质代谢方面可能不如其他两种药物有效。
相似文献
1
Comparison of the antilipolytic effect of metoprolol, acebutolol, and propranolol in man.美托洛尔、醋丁洛尔和普萘洛尔对人体抗脂解作用的比较。
Br Med J. 1977 Sep 3;2(6087):601-3. doi: 10.1136/bmj.2.6087.601.
2
Comparison of propranolol, metoprolol, and acebutolol on insulin-induced hypoglycaemia.普萘洛尔、美托洛尔和醋丁洛尔对胰岛素诱导的低血糖的比较。
Br Med J. 1976 Aug 21;2(6033):447-9. doi: 10.1136/bmj.2.6033.447.
3
Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.醋丁洛尔及其代谢产物双醋洛尔与美托洛尔和普萘洛尔在正常人体内的β-肾上腺素受体选择性比较。
Eur J Clin Pharmacol. 1986;29(6):679-83. doi: 10.1007/BF00615958.
4
Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.普萘洛尔、吲哚洛尔、醋氨心安、阿替洛尔、美托洛尔和醋丁洛尔对健康人体受试者中异丙肾上腺素诱导的血浆游离脂肪酸、免疫反应性胰岛素水平和血浆肾素活性变化的阻断作用。
Br J Clin Pharmacol. 1978 Jan;5(1):19-26. doi: 10.1111/j.1365-2125.1978.tb01593.x.
5
Acebutolol, metoprolol and propranolol in conscious dogs with chronic heart-block: chronotropic effects and relation between depression of ventricular activity and beta-adrenoceptor blocking potency.醋丁洛尔、美托洛尔和普萘洛尔对清醒慢性心脏传导阻滞犬的影响：变时作用及心室活动抑制与β-肾上腺素能受体阻断效能的关系
Br J Pharmacol. 1980 Oct;70(2):335-40. doi: 10.1111/j.1476-5381.1980.tb07941.x.
6
Effects of metoprolol and propranolol on lipid metabolism.
Int J Clin Pharmacol Biopharm. 1979 Sep;17(9):378-82.
7
Comparison of four beta-blockers as assessed by 24-hour ECG recording.通过24小时心电图记录评估四种β受体阻滞剂的比较。
Clin Pharmacol Ther. 1986 Apr;39(4):361-8. doi: 10.1038/clpt.1986.55.
8
9
Effect of beta-adrenoceptor blockade on exercise performance and metabolism.β-肾上腺素能受体阻断对运动能力和代谢的影响。
Clin Sci (Lond). 1981 Sep;61(3):299-305. doi: 10.1042/cs0610299.
10
Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration.普萘洛尔或美托洛尔给药后对β-肾上腺素能刺激的代谢反应差异。
Acta Med Scand. 1979;205(3):201-6. doi: 10.1111/j.0954-6820.1979.tb06031.x.
引用本文的文献
1
A pathophysiological compass to personalize antianginal drug treatment.一种病理生理学指南针，用于个性化抗心绞痛药物治疗。
Nat Rev Cardiol. 2021 Dec;18(12):838-852. doi: 10.1038/s41569-021-00573-w. Epub 2021 Jul 7.
2
Heart failure and loss of metabolic control.心力衰竭与代谢控制丧失。
J Cardiovasc Pharmacol. 2014 Apr;63(4):302-13. doi: 10.1097/FJC.0000000000000054.
3
Taking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy.关注糖尿病——糖尿病性心肌病中心肌脂质代谢失调
J Am Heart Assoc. 2013 Nov 25;2(6):e000433. doi: 10.1161/JAHA.113.000433.
4
Atenolol and metoprolol: comparison of effects on blood pressure and serum lipoproteins, and side effects.阿替洛尔和美托洛尔：对血压和血清脂蛋白的影响及副作用比较
Eur J Clin Pharmacol. 1983;24(5):573-7. doi: 10.1007/BF00542203.
5
Influence of propranolol on uptake of radioiodinated heptadecanoic acid and thallium-201 in the dog heart.普萘洛尔对犬心脏中放射性碘标记十七烷酸和铊-201摄取的影响。
Eur J Nucl Med. 1983;8(10):454-7. doi: 10.1007/BF00252946.
6
Divergent effects of atenolol, practolol and propranolol on the peripheral metabolic changes induced by dynamic exercise in healthy men.阿替洛尔、普拉洛尔和普萘洛尔对健康男性动态运动引起的外周代谢变化的不同影响。
Eur J Clin Pharmacol. 1983;25(3):293-7. doi: 10.1007/BF01037936.
7
Beta adrenoceptor antagonists after myocardial infarction--where are we now?心肌梗死后的β肾上腺素能受体拮抗剂——我们现在处于什么阶段？
Br Heart J. 1983 Feb;49(2):105-10. doi: 10.1136/hrt.49.2.105.
8
[Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].肾脏疾病中脂肪代谢的改变 - 发病机制（作者译）
Klin Wochenschr. 1982 Apr 1;60(7):327-36. doi: 10.1007/BF01721622.
9
Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension.普萘洛尔及β-肾上腺素能受体阻断药治疗高血压
Br J Clin Pharmacol. 1982 Jan;13(1):51-60. doi: 10.1111/j.1365-2125.1982.tb01336.x.
10
A comparison between propranolol, practolol and betaxolol (SL75212) on the circulatory and metabolic responses to insulin-induced hypoglycaemia.普萘洛尔、普拉洛尔和倍他洛尔（SL75212）对胰岛素诱导的低血糖症的循环和代谢反应的比较。
Eur J Clin Pharmacol. 1981;21(3):177-84. doi: 10.1007/BF00627917.
本文引用的文献
1
Titration of free fatty acids of plasma: a study of current methods and a new modification.血浆游离脂肪酸的滴定：当前方法研究及一种新改良方法
J Lipid Res. 1960 Apr;1:199-202.
2
A relation between non-esterified fatty acids in plasma and the metabolism of glucose.血浆中非酯化脂肪酸与葡萄糖代谢之间的关系。
J Clin Invest. 1956 Feb;35(2):150-4. doi: 10.1172/JCI103259.
3
Role of beta-adrenergic receptors in counterregulation to insulin-induced hypoglycemia.β-肾上腺素能受体在对抗胰岛素诱导的低血糖中的作用。
Diabetes. 1968 Mar;17(3):141-6. doi: 10.2337/diab.17.3.141.
4
Effect of a combination of propranolol and nicotinic acid on the inhibition of norepinephrine-induced elevations of serum triglyceride, serum glycerol, and plasma free fatty acids in the dog.普萘洛尔与烟酸联合使用对抑制去甲肾上腺素引起的犬血清甘油三酯、血清甘油及血浆游离脂肪酸升高的作用。
Metabolism. 1971 Jun;20(6):580-9. doi: 10.1016/0026-0495(71)90006-0.
5
Vagotonicity of violence: biochemical and cardiac responses to violent films and television programmes.暴力的迷走神经紧张性：对暴力电影和电视节目的生化及心脏反应。
Br Med J. 1973 Aug 18;3(5876):384-9. doi: 10.1136/bmj.3.5876.384.
6
Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.M&B 17803A的β-肾上腺素能受体阻断特性及心脏选择性
Br J Pharmacol. 1973 Jun;48(2):198-211. doi: 10.1111/j.1476-5381.1973.tb06906.x.
7
Pharmacokinetics of M&B 17,803A in animals and man.M&B 17,803A在动物和人体中的药代动力学。
Br J Pharmacol. 1973 Mar;47(3):620P.
8
Biochemical aspects of drug and hormone action on adipose tissue.药物和激素作用于脂肪组织的生化方面。
Pharmacol Rev. 1973 Mar;25(1):67-118.
9
Raised serum-lipids unaffected by beta-blockade.
Lancet. 1970 Nov 14;2(7681):1040. doi: 10.1016/s0140-6736(70)92862-x.
10
Comparison of antihypertensive activity of beta-blocking drugs during chronic treatment.β受体阻滞剂在长期治疗期间的降压活性比较。
Br Med J. 1976 Jul 3;2(6026):7-9. doi: 10.1136/bmj.2.6026.7.
Zotero 插件